nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2D6—Fingolimod—multiple sclerosis	0.045	0.223	CbGbCtD
Mirtazapine—HTR3A—area postrema—multiple sclerosis	0.0348	0.183	CbGeAlD
Mirtazapine—CYP3A4—Fingolimod—multiple sclerosis	0.0286	0.142	CbGbCtD
Mirtazapine—HTR2A—trigeminal nucleus—multiple sclerosis	0.019	0.1	CbGeAlD
Mirtazapine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0184	0.0915	CbGbCtD
Mirtazapine—CYP2C8—Dexamethasone—multiple sclerosis	0.0172	0.0853	CbGbCtD
Mirtazapine—CYP3A4—Triamcinolone—multiple sclerosis	0.014	0.0693	CbGbCtD
Mirtazapine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0134	0.0667	CbGbCtD
Mirtazapine—CYP2C9—Dexamethasone—multiple sclerosis	0.012	0.0595	CbGbCtD
Mirtazapine—CYP3A4—Betamethasone—multiple sclerosis	0.012	0.0595	CbGbCtD
Mirtazapine—CYP3A4—Prednisolone—multiple sclerosis	0.0118	0.0587	CbGbCtD
Mirtazapine—CYP3A4—Prednisone—multiple sclerosis	0.0112	0.0554	CbGbCtD
Mirtazapine—CYP2D6—Dexamethasone—multiple sclerosis	0.011	0.0544	CbGbCtD
Mirtazapine—CYP3A4—Dexamethasone—multiple sclerosis	0.00697	0.0346	CbGbCtD
Mirtazapine—HTR7—pons—multiple sclerosis	0.00564	0.0296	CbGeAlD
Mirtazapine—HTR2A—trigeminal nerve—multiple sclerosis	0.005	0.0263	CbGeAlD
Mirtazapine—HTR3A—nerve—multiple sclerosis	0.00452	0.0238	CbGeAlD
Mirtazapine—HRH3—brainstem—multiple sclerosis	0.00405	0.0213	CbGeAlD
Mirtazapine—SLC6A3—nerve—multiple sclerosis	0.00376	0.0198	CbGeAlD
Mirtazapine—HTR7—peripheral nervous system—multiple sclerosis	0.00375	0.0197	CbGeAlD
Mirtazapine—HTR2A—pons—multiple sclerosis	0.00352	0.0185	CbGeAlD
Mirtazapine—SLC6A2—nerve—multiple sclerosis	0.00304	0.016	CbGeAlD
Mirtazapine—HTR7—nerve—multiple sclerosis	0.00293	0.0154	CbGeAlD
Mirtazapine—DRD2—nerve—multiple sclerosis	0.00277	0.0145	CbGeAlD
Mirtazapine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00275	0.0145	CbGeAlD
Mirtazapine—HTR2A—pineal body—multiple sclerosis	0.00251	0.0132	CbGeAlD
Mirtazapine—HTR2A—peripheral nervous system—multiple sclerosis	0.00234	0.0123	CbGeAlD
Mirtazapine—HRH3—nervous system—multiple sclerosis	0.00212	0.0112	CbGeAlD
Mirtazapine—HRH3—central nervous system—multiple sclerosis	0.00204	0.0107	CbGeAlD
Mirtazapine—HRH3—cerebellum—multiple sclerosis	0.002	0.0105	CbGeAlD
Mirtazapine—HTR3A—brainstem—multiple sclerosis	0.00194	0.0102	CbGeAlD
Mirtazapine—HTR2A—nerve—multiple sclerosis	0.00183	0.00959	CbGeAlD
Mirtazapine—HRH3—brain—multiple sclerosis	0.00162	0.00852	CbGeAlD
Mirtazapine—SLC6A3—brainstem—multiple sclerosis	0.00162	0.00849	CbGeAlD
Mirtazapine—DRD4—brain—multiple sclerosis	0.0016	0.0084	CbGeAlD
Mirtazapine—HTR2C—brainstem—multiple sclerosis	0.00156	0.00821	CbGeAlD
Mirtazapine—SLC6A4—brainstem—multiple sclerosis	0.00148	0.00778	CbGeAlD
Mirtazapine—DRD3—nervous system—multiple sclerosis	0.00147	0.00773	CbGeAlD
Mirtazapine—DRD3—central nervous system—multiple sclerosis	0.00142	0.00744	CbGeAlD
Mirtazapine—HTR1A—brainstem—multiple sclerosis	0.00131	0.00691	CbGeAlD
Mirtazapine—OPRK1—nervous system—multiple sclerosis	0.00131	0.00689	CbGeAlD
Mirtazapine—SLC6A2—brainstem—multiple sclerosis	0.0013	0.00685	CbGeAlD
Mirtazapine—OPRK1—central nervous system—multiple sclerosis	0.00126	0.00663	CbGeAlD
Mirtazapine—HTR7—brainstem—multiple sclerosis	0.00126	0.0066	CbGeAlD
Mirtazapine—OPRK1—cerebellum—multiple sclerosis	0.00123	0.00648	CbGeAlD
Mirtazapine—ADRA1A—brainstem—multiple sclerosis	0.00121	0.00637	CbGeAlD
Mirtazapine—DRD2—brainstem—multiple sclerosis	0.00119	0.00624	CbGeAlD
Mirtazapine—DRD2—retina—multiple sclerosis	0.00115	0.00602	CbGeAlD
Mirtazapine—DRD3—brain—multiple sclerosis	0.00112	0.00591	CbGeAlD
Mirtazapine—HTR2C—medulla oblongata—multiple sclerosis	0.00109	0.00572	CbGeAlD
Mirtazapine—SLC6A3—midbrain—multiple sclerosis	0.00103	0.00541	CbGeAlD
Mirtazapine—HTR3A—nervous system—multiple sclerosis	0.00102	0.00535	CbGeAlD
Mirtazapine—SLC6A3—spinal cord—multiple sclerosis	0.001	0.00528	CbGeAlD
Mirtazapine—OPRK1—brain—multiple sclerosis	0.001	0.00527	CbGeAlD
Mirtazapine—HTR2C—midbrain—multiple sclerosis	0.000996	0.00523	CbGeAlD
Mirtazapine—HTR3A—central nervous system—multiple sclerosis	0.00098	0.00515	CbGeAlD
Mirtazapine—HTR2C—spinal cord—multiple sclerosis	0.000971	0.0051	CbGeAlD
Mirtazapine—SLC6A4—midbrain—multiple sclerosis	0.000944	0.00496	CbGeAlD
Mirtazapine—SLC6A4—spinal cord—multiple sclerosis	0.000921	0.00484	CbGeAlD
Mirtazapine—SLC6A2—medulla oblongata—multiple sclerosis	0.000909	0.00478	CbGeAlD
Mirtazapine—HTR7—medulla oblongata—multiple sclerosis	0.000876	0.0046	CbGeAlD
Mirtazapine—SLC6A3—nervous system—multiple sclerosis	0.000847	0.00445	CbGeAlD
Mirtazapine—HTR1A—midbrain—multiple sclerosis	0.000838	0.0044	CbGeAlD
Mirtazapine—HTR2C—nervous system—multiple sclerosis	0.000818	0.0043	CbGeAlD
Mirtazapine—HTR1A—spinal cord—multiple sclerosis	0.000818	0.0043	CbGeAlD
Mirtazapine—SLC6A3—central nervous system—multiple sclerosis	0.000815	0.00428	CbGeAlD
Mirtazapine—ADRA2C—medulla oblongata—multiple sclerosis	0.000805	0.00423	CbGeAlD
Mirtazapine—ADRB1—nervous system—multiple sclerosis	0.000803	0.00422	CbGeAlD
Mirtazapine—HTR7—midbrain—multiple sclerosis	0.000801	0.00421	CbGeAlD
Mirtazapine—SLC6A3—cerebellum—multiple sclerosis	0.000797	0.00419	CbGeAlD
Mirtazapine—HTR2C—central nervous system—multiple sclerosis	0.000788	0.00414	CbGeAlD
Mirtazapine—HTR2A—brainstem—multiple sclerosis	0.000784	0.00412	CbGeAlD
Mirtazapine—HTR7—spinal cord—multiple sclerosis	0.000781	0.0041	CbGeAlD
Mirtazapine—HTR3A—brain—multiple sclerosis	0.000778	0.00409	CbGeAlD
Mirtazapine—SLC6A4—nervous system—multiple sclerosis	0.000776	0.00408	CbGeAlD
Mirtazapine—ADRB1—central nervous system—multiple sclerosis	0.000773	0.00406	CbGeAlD
Mirtazapine—HTR2B—nervous system—multiple sclerosis	0.000769	0.00404	CbGeAlD
Mirtazapine—DRD2—midbrain—multiple sclerosis	0.000757	0.00398	CbGeAlD
Mirtazapine—HTR2A—retina—multiple sclerosis	0.000756	0.00397	CbGeAlD
Mirtazapine—SLC6A4—central nervous system—multiple sclerosis	0.000747	0.00392	CbGeAlD
Mirtazapine—HTR2B—central nervous system—multiple sclerosis	0.00074	0.00389	CbGeAlD
Mirtazapine—ADRA2C—midbrain—multiple sclerosis	0.000736	0.00387	CbGeAlD
Mirtazapine—ADRA2C—spinal cord—multiple sclerosis	0.000718	0.00377	CbGeAlD
Mirtazapine—CYP2D6—brainstem—multiple sclerosis	0.000714	0.00375	CbGeAlD
Mirtazapine—HTR1A—nervous system—multiple sclerosis	0.000689	0.00362	CbGeAlD
Mirtazapine—SLC6A2—nervous system—multiple sclerosis	0.000683	0.00359	CbGeAlD
Mirtazapine—HTR1A—central nervous system—multiple sclerosis	0.000663	0.00348	CbGeAlD
Mirtazapine—HTR7—nervous system—multiple sclerosis	0.000658	0.00346	CbGeAlD
Mirtazapine—SLC6A2—central nervous system—multiple sclerosis	0.000658	0.00345	CbGeAlD
Mirtazapine—HTR1A—cerebellum—multiple sclerosis	0.000648	0.00341	CbGeAlD
Mirtazapine—SLC6A3—brain—multiple sclerosis	0.000647	0.0034	CbGeAlD
Mirtazapine—ADRA2A—medulla oblongata—multiple sclerosis	0.000643	0.00338	CbGeAlD
Mirtazapine—ADRA1A—nervous system—multiple sclerosis	0.000635	0.00334	CbGeAlD
Mirtazapine—HTR7—central nervous system—multiple sclerosis	0.000634	0.00333	CbGeAlD
Mirtazapine—HTR2C—brain—multiple sclerosis	0.000626	0.00329	CbGeAlD
Mirtazapine—DRD2—nervous system—multiple sclerosis	0.000622	0.00327	CbGeAlD
Mirtazapine—HTR7—cerebellum—multiple sclerosis	0.00062	0.00325	CbGeAlD
Mirtazapine—ADRB1—brain—multiple sclerosis	0.000614	0.00322	CbGeAlD
Mirtazapine—ADRA1A—central nervous system—multiple sclerosis	0.000611	0.00321	CbGeAlD
Mirtazapine—ADRA2C—nervous system—multiple sclerosis	0.000605	0.00318	CbGeAlD
Mirtazapine—DRD2—central nervous system—multiple sclerosis	0.000599	0.00315	CbGeAlD
Mirtazapine—ADRA1A—cerebellum—multiple sclerosis	0.000598	0.00314	CbGeAlD
Mirtazapine—SLC6A4—brain—multiple sclerosis	0.000593	0.00312	CbGeAlD
Mirtazapine—HTR2B—brain—multiple sclerosis	0.000588	0.00309	CbGeAlD
Mirtazapine—ADRA2A—midbrain—multiple sclerosis	0.000587	0.00309	CbGeAlD
Mirtazapine—DRD2—cerebellum—multiple sclerosis	0.000586	0.00308	CbGeAlD
Mirtazapine—ADRA2C—central nervous system—multiple sclerosis	0.000583	0.00306	CbGeAlD
Mirtazapine—ADRA2A—spinal cord—multiple sclerosis	0.000573	0.00301	CbGeAlD
Mirtazapine—ADRA2C—cerebellum—multiple sclerosis	0.000569	0.00299	CbGeAlD
Mirtazapine—HTR2A—medulla oblongata—multiple sclerosis	0.000546	0.00287	CbGeAlD
Mirtazapine—HTR1A—brain—multiple sclerosis	0.000527	0.00277	CbGeAlD
Mirtazapine—SLC6A2—brain—multiple sclerosis	0.000522	0.00274	CbGeAlD
Mirtazapine—HTR7—brain—multiple sclerosis	0.000503	0.00264	CbGeAlD
Mirtazapine—HTR2A—midbrain—multiple sclerosis	0.000499	0.00262	CbGeAlD
Mirtazapine—HRH1—nervous system—multiple sclerosis	0.000492	0.00258	CbGeAlD
Mirtazapine—HTR2A—spinal cord—multiple sclerosis	0.000487	0.00256	CbGeAlD
Mirtazapine—ADRA1A—brain—multiple sclerosis	0.000485	0.00255	CbGeAlD
Mirtazapine—ADRA2A—nervous system—multiple sclerosis	0.000483	0.00254	CbGeAlD
Mirtazapine—DRD2—brain—multiple sclerosis	0.000476	0.0025	CbGeAlD
Mirtazapine—HRH1—central nervous system—multiple sclerosis	0.000473	0.00249	CbGeAlD
Mirtazapine—ADRA2A—central nervous system—multiple sclerosis	0.000465	0.00244	CbGeAlD
Mirtazapine—ADRA2C—brain—multiple sclerosis	0.000463	0.00243	CbGeAlD
Mirtazapine—ADRA2A—cerebellum—multiple sclerosis	0.000454	0.00239	CbGeAlD
Mirtazapine—CYP2C8—brain—multiple sclerosis	0.000429	0.00225	CbGeAlD
Mirtazapine—HTR2A—nervous system—multiple sclerosis	0.000411	0.00216	CbGeAlD
Mirtazapine—HTR2A—central nervous system—multiple sclerosis	0.000395	0.00208	CbGeAlD
Mirtazapine—HTR2A—cerebellum—multiple sclerosis	0.000386	0.00203	CbGeAlD
Mirtazapine—CYP3A4—nervous system—multiple sclerosis	0.00038	0.002	CbGeAlD
Mirtazapine—HRH1—brain—multiple sclerosis	0.000376	0.00197	CbGeAlD
Mirtazapine—CYP2D6—nervous system—multiple sclerosis	0.000374	0.00196	CbGeAlD
Mirtazapine—ADRA2A—brain—multiple sclerosis	0.000369	0.00194	CbGeAlD
Mirtazapine—CYP3A4—central nervous system—multiple sclerosis	0.000366	0.00192	CbGeAlD
Mirtazapine—CYP2D6—central nervous system—multiple sclerosis	0.00036	0.00189	CbGeAlD
Mirtazapine—CYP2D6—cerebellum—multiple sclerosis	0.000352	0.00185	CbGeAlD
Mirtazapine—HTR2A—brain—multiple sclerosis	0.000314	0.00165	CbGeAlD
Mirtazapine—CYP2D6—brain—multiple sclerosis	0.000286	0.0015	CbGeAlD
Mirtazapine—Insomnia—Prednisolone—multiple sclerosis	0.000199	0.00049	CcSEcCtD
Mirtazapine—Alopecia—Prednisone—multiple sclerosis	0.000199	0.000489	CcSEcCtD
Mirtazapine—Shock—Methylprednisolone—multiple sclerosis	0.000199	0.000489	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000198	0.000488	CcSEcCtD
Mirtazapine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000198	0.000487	CcSEcCtD
Mirtazapine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000198	0.000487	CcSEcCtD
Mirtazapine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000198	0.000487	CcSEcCtD
Mirtazapine—Epistaxis—Methotrexate—multiple sclerosis	0.000197	0.000486	CcSEcCtD
Mirtazapine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000197	0.000486	CcSEcCtD
Mirtazapine—Paraesthesia—Prednisolone—multiple sclerosis	0.000197	0.000486	CcSEcCtD
Mirtazapine—Tachycardia—Triamcinolone—multiple sclerosis	0.000197	0.000486	CcSEcCtD
Mirtazapine—Mental disorder—Prednisone—multiple sclerosis	0.000197	0.000485	CcSEcCtD
Mirtazapine—Nausea—Azathioprine—multiple sclerosis	0.000197	0.000485	CcSEcCtD
Mirtazapine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000197	0.000485	CcSEcCtD
Mirtazapine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000196	0.000483	CcSEcCtD
Mirtazapine—Malnutrition—Prednisone—multiple sclerosis	0.000196	0.000482	CcSEcCtD
Mirtazapine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000195	0.000481	CcSEcCtD
Mirtazapine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000195	0.000481	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000195	0.00048	CcSEcCtD
Mirtazapine—Convulsion—Betamethasone—multiple sclerosis	0.000195	0.00048	CcSEcCtD
Mirtazapine—Convulsion—Dexamethasone—multiple sclerosis	0.000195	0.00048	CcSEcCtD
Mirtazapine—Hypertension—Dexamethasone—multiple sclerosis	0.000194	0.000478	CcSEcCtD
Mirtazapine—Hypertension—Betamethasone—multiple sclerosis	0.000194	0.000478	CcSEcCtD
Mirtazapine—Asthenia—Mitoxantrone—multiple sclerosis	0.000192	0.000474	CcSEcCtD
Mirtazapine—Myalgia—Dexamethasone—multiple sclerosis	0.000191	0.000471	CcSEcCtD
Mirtazapine—Myalgia—Betamethasone—multiple sclerosis	0.000191	0.000471	CcSEcCtD
Mirtazapine—Anxiety—Betamethasone—multiple sclerosis	0.000191	0.00047	CcSEcCtD
Mirtazapine—Anxiety—Dexamethasone—multiple sclerosis	0.000191	0.00047	CcSEcCtD
Mirtazapine—Discomfort—Betamethasone—multiple sclerosis	0.000189	0.000466	CcSEcCtD
Mirtazapine—Discomfort—Dexamethasone—multiple sclerosis	0.000189	0.000466	CcSEcCtD
Mirtazapine—Hypotension—Methylprednisolone—multiple sclerosis	0.000189	0.000464	CcSEcCtD
Mirtazapine—Pain—Prednisolone—multiple sclerosis	0.000188	0.000463	CcSEcCtD
Mirtazapine—Hepatitis—Methotrexate—multiple sclerosis	0.000188	0.000463	CcSEcCtD
Mirtazapine—Pharyngitis—Methotrexate—multiple sclerosis	0.000187	0.000459	CcSEcCtD
Mirtazapine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000186	0.000457	CcSEcCtD
Mirtazapine—Urethral disorder—Methotrexate—multiple sclerosis	0.000184	0.000454	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000184	0.000454	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000184	0.000453	CcSEcCtD
Mirtazapine—Oedema—Betamethasone—multiple sclerosis	0.000183	0.000452	CcSEcCtD
Mirtazapine—Oedema—Dexamethasone—multiple sclerosis	0.000183	0.000452	CcSEcCtD
Mirtazapine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000183	0.000452	CcSEcCtD
Mirtazapine—Insomnia—Triamcinolone—multiple sclerosis	0.000183	0.00045	CcSEcCtD
Mirtazapine—Insomnia—Methylprednisolone—multiple sclerosis	0.000182	0.000449	CcSEcCtD
Mirtazapine—Infection—Dexamethasone—multiple sclerosis	0.000182	0.000449	CcSEcCtD
Mirtazapine—Infection—Betamethasone—multiple sclerosis	0.000182	0.000449	CcSEcCtD
Mirtazapine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000182	0.000447	CcSEcCtD
Mirtazapine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000182	0.000447	CcSEcCtD
Mirtazapine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000181	0.000446	CcSEcCtD
Mirtazapine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000181	0.000446	CcSEcCtD
Mirtazapine—Anaemia—Prednisone—multiple sclerosis	0.000181	0.000446	CcSEcCtD
Mirtazapine—Shock—Dexamethasone—multiple sclerosis	0.000181	0.000445	CcSEcCtD
Mirtazapine—Shock—Betamethasone—multiple sclerosis	0.000181	0.000445	CcSEcCtD
Mirtazapine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00018	0.000444	CcSEcCtD
Mirtazapine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00018	0.000443	CcSEcCtD
Mirtazapine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00018	0.000443	CcSEcCtD
Mirtazapine—Agitation—Prednisone—multiple sclerosis	0.00018	0.000443	CcSEcCtD
Mirtazapine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00018	0.000442	CcSEcCtD
Mirtazapine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00018	0.000442	CcSEcCtD
Mirtazapine—Tachycardia—Dexamethasone—multiple sclerosis	0.000179	0.000441	CcSEcCtD
Mirtazapine—Tachycardia—Betamethasone—multiple sclerosis	0.000179	0.000441	CcSEcCtD
Mirtazapine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000178	0.000438	CcSEcCtD
Mirtazapine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000178	0.000438	CcSEcCtD
Mirtazapine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000178	0.000437	CcSEcCtD
Mirtazapine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000177	0.000437	CcSEcCtD
Mirtazapine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000177	0.000437	CcSEcCtD
Mirtazapine—Malaise—Prednisone—multiple sclerosis	0.000177	0.000435	CcSEcCtD
Mirtazapine—Vertigo—Prednisone—multiple sclerosis	0.000176	0.000433	CcSEcCtD
Mirtazapine—Eye disorder—Methotrexate—multiple sclerosis	0.000176	0.000433	CcSEcCtD
Mirtazapine—Syncope—Prednisone—multiple sclerosis	0.000176	0.000432	CcSEcCtD
Mirtazapine—Tinnitus—Methotrexate—multiple sclerosis	0.000175	0.000432	CcSEcCtD
Mirtazapine—Anorexia—Betamethasone—multiple sclerosis	0.000175	0.000431	CcSEcCtD
Mirtazapine—Anorexia—Dexamethasone—multiple sclerosis	0.000175	0.000431	CcSEcCtD
Mirtazapine—Urticaria—Prednisolone—multiple sclerosis	0.000175	0.00043	CcSEcCtD
Mirtazapine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000174	0.00043	CcSEcCtD
Mirtazapine—Fatigue—Triamcinolone—multiple sclerosis	0.000174	0.000429	CcSEcCtD
Mirtazapine—Fatigue—Methylprednisolone—multiple sclerosis	0.000174	0.000428	CcSEcCtD
Mirtazapine—Pain—Triamcinolone—multiple sclerosis	0.000173	0.000426	CcSEcCtD
Mirtazapine—Loss of consciousness—Prednisone—multiple sclerosis	0.000172	0.000424	CcSEcCtD
Mirtazapine—Hypotension—Dexamethasone—multiple sclerosis	0.000171	0.000422	CcSEcCtD
Mirtazapine—Hypotension—Betamethasone—multiple sclerosis	0.000171	0.000422	CcSEcCtD
Mirtazapine—Angiopathy—Methotrexate—multiple sclerosis	0.000171	0.00042	CcSEcCtD
Mirtazapine—Vomiting—Mitoxantrone—multiple sclerosis	0.00017	0.00042	CcSEcCtD
Mirtazapine—Convulsion—Prednisone—multiple sclerosis	0.00017	0.000418	CcSEcCtD
Mirtazapine—Hypertension—Prednisone—multiple sclerosis	0.000169	0.000416	CcSEcCtD
Mirtazapine—Rash—Mitoxantrone—multiple sclerosis	0.000169	0.000416	CcSEcCtD
Mirtazapine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000169	0.000416	CcSEcCtD
Mirtazapine—Chills—Methotrexate—multiple sclerosis	0.000169	0.000415	CcSEcCtD
Mirtazapine—Headache—Mitoxantrone—multiple sclerosis	0.000168	0.000414	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000167	0.000412	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000167	0.000412	CcSEcCtD
Mirtazapine—Arthralgia—Prednisone—multiple sclerosis	0.000167	0.000411	CcSEcCtD
Mirtazapine—Myalgia—Prednisone—multiple sclerosis	0.000167	0.000411	CcSEcCtD
Mirtazapine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000167	0.00041	CcSEcCtD
Mirtazapine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000166	0.00041	CcSEcCtD
Mirtazapine—Anxiety—Prednisone—multiple sclerosis	0.000166	0.000409	CcSEcCtD
Mirtazapine—Alopecia—Methotrexate—multiple sclerosis	0.000166	0.000409	CcSEcCtD
Mirtazapine—Insomnia—Dexamethasone—multiple sclerosis	0.000166	0.000409	CcSEcCtD
Mirtazapine—Insomnia—Betamethasone—multiple sclerosis	0.000166	0.000409	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000166	0.000408	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000165	0.000406	CcSEcCtD
Mirtazapine—Paraesthesia—Betamethasone—multiple sclerosis	0.000165	0.000406	CcSEcCtD
Mirtazapine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000165	0.000406	CcSEcCtD
Mirtazapine—Discomfort—Prednisone—multiple sclerosis	0.000165	0.000406	CcSEcCtD
Mirtazapine—Mental disorder—Methotrexate—multiple sclerosis	0.000165	0.000406	CcSEcCtD
Mirtazapine—Malnutrition—Methotrexate—multiple sclerosis	0.000164	0.000403	CcSEcCtD
Mirtazapine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000162	0.000399	CcSEcCtD
Mirtazapine—Dyspepsia—Betamethasone—multiple sclerosis	0.000162	0.000398	CcSEcCtD
Mirtazapine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000162	0.000398	CcSEcCtD
Mirtazapine—Urticaria—Triamcinolone—multiple sclerosis	0.000161	0.000396	CcSEcCtD
Mirtazapine—Urticaria—Methylprednisolone—multiple sclerosis	0.00016	0.000395	CcSEcCtD
Mirtazapine—Dysgeusia—Methotrexate—multiple sclerosis	0.00016	0.000395	CcSEcCtD
Mirtazapine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00016	0.000394	CcSEcCtD
Mirtazapine—Oedema—Prednisone—multiple sclerosis	0.00016	0.000394	CcSEcCtD
Mirtazapine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000159	0.000393	CcSEcCtD
Mirtazapine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000159	0.000393	CcSEcCtD
Mirtazapine—Decreased appetite—Betamethasone—multiple sclerosis	0.000159	0.000393	CcSEcCtD
Mirtazapine—Nausea—Mitoxantrone—multiple sclerosis	0.000159	0.000392	CcSEcCtD
Mirtazapine—Infection—Prednisone—multiple sclerosis	0.000159	0.000391	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000158	0.00039	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000158	0.00039	CcSEcCtD
Mirtazapine—Back pain—Methotrexate—multiple sclerosis	0.000158	0.00039	CcSEcCtD
Mirtazapine—Fatigue—Dexamethasone—multiple sclerosis	0.000158	0.00039	CcSEcCtD
Mirtazapine—Fatigue—Betamethasone—multiple sclerosis	0.000158	0.00039	CcSEcCtD
Mirtazapine—Shock—Prednisone—multiple sclerosis	0.000157	0.000387	CcSEcCtD
Mirtazapine—Pain—Betamethasone—multiple sclerosis	0.000157	0.000386	CcSEcCtD
Mirtazapine—Pain—Dexamethasone—multiple sclerosis	0.000157	0.000386	CcSEcCtD
Mirtazapine—Nervous system disorder—Prednisone—multiple sclerosis	0.000157	0.000386	CcSEcCtD
Mirtazapine—Tachycardia—Prednisone—multiple sclerosis	0.000156	0.000384	CcSEcCtD
Mirtazapine—Skin disorder—Prednisone—multiple sclerosis	0.000155	0.000382	CcSEcCtD
Mirtazapine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000154	0.00038	CcSEcCtD
Mirtazapine—Anorexia—Prednisone—multiple sclerosis	0.000152	0.000375	CcSEcCtD
Mirtazapine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000152	0.000374	CcSEcCtD
Mirtazapine—Anaemia—Methotrexate—multiple sclerosis	0.000151	0.000372	CcSEcCtD
Mirtazapine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000151	0.000372	CcSEcCtD
Mirtazapine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000151	0.000372	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00015	0.00037	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00015	0.00037	CcSEcCtD
Mirtazapine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000149	0.000367	CcSEcCtD
Mirtazapine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000149	0.000366	CcSEcCtD
Mirtazapine—Malaise—Methotrexate—multiple sclerosis	0.000148	0.000363	CcSEcCtD
Mirtazapine—Vertigo—Methotrexate—multiple sclerosis	0.000147	0.000362	CcSEcCtD
Mirtazapine—Leukopenia—Methotrexate—multiple sclerosis	0.000146	0.000361	CcSEcCtD
Mirtazapine—Urticaria—Dexamethasone—multiple sclerosis	0.000146	0.000359	CcSEcCtD
Mirtazapine—Urticaria—Betamethasone—multiple sclerosis	0.000146	0.000359	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000146	0.000359	CcSEcCtD
Mirtazapine—Dizziness—Prednisolone—multiple sclerosis	0.000145	0.000358	CcSEcCtD
Mirtazapine—Asthenia—Triamcinolone—multiple sclerosis	0.000145	0.000357	CcSEcCtD
Mirtazapine—Abdominal pain—Betamethasone—multiple sclerosis	0.000145	0.000357	CcSEcCtD
Mirtazapine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000145	0.000357	CcSEcCtD
Mirtazapine—Body temperature increased—Betamethasone—multiple sclerosis	0.000145	0.000357	CcSEcCtD
Mirtazapine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000145	0.000357	CcSEcCtD
Mirtazapine—Asthenia—Methylprednisolone—multiple sclerosis	0.000145	0.000357	CcSEcCtD
Mirtazapine—Insomnia—Prednisone—multiple sclerosis	0.000145	0.000356	CcSEcCtD
Mirtazapine—Paraesthesia—Prednisone—multiple sclerosis	0.000143	0.000353	CcSEcCtD
Mirtazapine—Pruritus—Triamcinolone—multiple sclerosis	0.000143	0.000352	CcSEcCtD
Mirtazapine—Cough—Methotrexate—multiple sclerosis	0.000143	0.000352	CcSEcCtD
Mirtazapine—Pruritus—Methylprednisolone—multiple sclerosis	0.000143	0.000352	CcSEcCtD
Mirtazapine—Convulsion—Methotrexate—multiple sclerosis	0.000142	0.000349	CcSEcCtD
Mirtazapine—Dyspepsia—Prednisone—multiple sclerosis	0.000141	0.000346	CcSEcCtD
Mirtazapine—Arthralgia—Methotrexate—multiple sclerosis	0.000139	0.000343	CcSEcCtD
Mirtazapine—Chest pain—Methotrexate—multiple sclerosis	0.000139	0.000343	CcSEcCtD
Mirtazapine—Myalgia—Methotrexate—multiple sclerosis	0.000139	0.000343	CcSEcCtD
Mirtazapine—Decreased appetite—Prednisone—multiple sclerosis	0.000139	0.000342	CcSEcCtD
Mirtazapine—Rash—Prednisolone—multiple sclerosis	0.000139	0.000341	CcSEcCtD
Mirtazapine—Dermatitis—Prednisolone—multiple sclerosis	0.000139	0.000341	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000138	0.000341	CcSEcCtD
Mirtazapine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000138	0.00034	CcSEcCtD
Mirtazapine—Fatigue—Prednisone—multiple sclerosis	0.000138	0.000339	CcSEcCtD
Mirtazapine—Headache—Prednisolone—multiple sclerosis	0.000138	0.000339	CcSEcCtD
Mirtazapine—Discomfort—Methotrexate—multiple sclerosis	0.000138	0.000339	CcSEcCtD
Mirtazapine—Constipation—Prednisone—multiple sclerosis	0.000137	0.000337	CcSEcCtD
Mirtazapine—Confusional state—Methotrexate—multiple sclerosis	0.000135	0.000332	CcSEcCtD
Mirtazapine—Dizziness—Triamcinolone—multiple sclerosis	0.000134	0.000329	CcSEcCtD
Mirtazapine—Dizziness—Methylprednisolone—multiple sclerosis	0.000133	0.000329	CcSEcCtD
Mirtazapine—Infection—Methotrexate—multiple sclerosis	0.000133	0.000327	CcSEcCtD
Mirtazapine—Feeling abnormal—Prednisone—multiple sclerosis	0.000132	0.000324	CcSEcCtD
Mirtazapine—Asthenia—Betamethasone—multiple sclerosis	0.000132	0.000324	CcSEcCtD
Mirtazapine—Asthenia—Dexamethasone—multiple sclerosis	0.000132	0.000324	CcSEcCtD
Mirtazapine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000131	0.000323	CcSEcCtD
Mirtazapine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000131	0.000322	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000131	0.000322	CcSEcCtD
Mirtazapine—Nausea—Prednisolone—multiple sclerosis	0.000131	0.000322	CcSEcCtD
Mirtazapine—Pruritus—Dexamethasone—multiple sclerosis	0.00013	0.00032	CcSEcCtD
Mirtazapine—Pruritus—Betamethasone—multiple sclerosis	0.00013	0.00032	CcSEcCtD
Mirtazapine—Skin disorder—Methotrexate—multiple sclerosis	0.00013	0.000319	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000129	0.000318	CcSEcCtD
Mirtazapine—Vomiting—Triamcinolone—multiple sclerosis	0.000129	0.000317	CcSEcCtD
Mirtazapine—Vomiting—Methylprednisolone—multiple sclerosis	0.000128	0.000316	CcSEcCtD
Mirtazapine—Rash—Triamcinolone—multiple sclerosis	0.000128	0.000314	CcSEcCtD
Mirtazapine—Dermatitis—Triamcinolone—multiple sclerosis	0.000127	0.000314	CcSEcCtD
Mirtazapine—Anorexia—Methotrexate—multiple sclerosis	0.000127	0.000314	CcSEcCtD
Mirtazapine—Rash—Methylprednisolone—multiple sclerosis	0.000127	0.000313	CcSEcCtD
Mirtazapine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000127	0.000313	CcSEcCtD
Mirtazapine—Urticaria—Prednisone—multiple sclerosis	0.000127	0.000313	CcSEcCtD
Mirtazapine—Headache—Triamcinolone—multiple sclerosis	0.000127	0.000312	CcSEcCtD
Mirtazapine—Headache—Methylprednisolone—multiple sclerosis	0.000126	0.000311	CcSEcCtD
Mirtazapine—Abdominal pain—Prednisone—multiple sclerosis	0.000126	0.000311	CcSEcCtD
Mirtazapine—Body temperature increased—Prednisone—multiple sclerosis	0.000126	0.000311	CcSEcCtD
Mirtazapine—Diarrhoea—Betamethasone—multiple sclerosis	0.000126	0.000309	CcSEcCtD
Mirtazapine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000126	0.000309	CcSEcCtD
Mirtazapine—Hypotension—Methotrexate—multiple sclerosis	0.000125	0.000307	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000122	0.0003	CcSEcCtD
Mirtazapine—Dizziness—Dexamethasone—multiple sclerosis	0.000121	0.000299	CcSEcCtD
Mirtazapine—Dizziness—Betamethasone—multiple sclerosis	0.000121	0.000299	CcSEcCtD
Mirtazapine—Insomnia—Methotrexate—multiple sclerosis	0.000121	0.000297	CcSEcCtD
Mirtazapine—Nausea—Triamcinolone—multiple sclerosis	0.00012	0.000296	CcSEcCtD
Mirtazapine—Paraesthesia—Methotrexate—multiple sclerosis	0.00012	0.000295	CcSEcCtD
Mirtazapine—Nausea—Methylprednisolone—multiple sclerosis	0.00012	0.000295	CcSEcCtD
Mirtazapine—Dyspnoea—Methotrexate—multiple sclerosis	0.000119	0.000293	CcSEcCtD
Mirtazapine—Somnolence—Methotrexate—multiple sclerosis	0.000119	0.000292	CcSEcCtD
Mirtazapine—Hypersensitivity—Prednisone—multiple sclerosis	0.000118	0.00029	CcSEcCtD
Mirtazapine—Dyspepsia—Methotrexate—multiple sclerosis	0.000118	0.00029	CcSEcCtD
Mirtazapine—Vomiting—Betamethasone—multiple sclerosis	0.000117	0.000287	CcSEcCtD
Mirtazapine—Vomiting—Dexamethasone—multiple sclerosis	0.000117	0.000287	CcSEcCtD
Mirtazapine—Decreased appetite—Methotrexate—multiple sclerosis	0.000116	0.000286	CcSEcCtD
Mirtazapine—Rash—Dexamethasone—multiple sclerosis	0.000116	0.000285	CcSEcCtD
Mirtazapine—Rash—Betamethasone—multiple sclerosis	0.000116	0.000285	CcSEcCtD
Mirtazapine—Dermatitis—Dexamethasone—multiple sclerosis	0.000116	0.000285	CcSEcCtD
Mirtazapine—Dermatitis—Betamethasone—multiple sclerosis	0.000116	0.000285	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000115	0.000284	CcSEcCtD
Mirtazapine—Fatigue—Methotrexate—multiple sclerosis	0.000115	0.000284	CcSEcCtD
Mirtazapine—Headache—Dexamethasone—multiple sclerosis	0.000115	0.000283	CcSEcCtD
Mirtazapine—Headache—Betamethasone—multiple sclerosis	0.000115	0.000283	CcSEcCtD
Mirtazapine—Asthenia—Prednisone—multiple sclerosis	0.000115	0.000282	CcSEcCtD
Mirtazapine—Pain—Methotrexate—multiple sclerosis	0.000114	0.000281	CcSEcCtD
Mirtazapine—Pruritus—Prednisone—multiple sclerosis	0.000113	0.000278	CcSEcCtD
Mirtazapine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00011	0.000271	CcSEcCtD
Mirtazapine—Diarrhoea—Prednisone—multiple sclerosis	0.000109	0.000269	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000109	0.000269	CcSEcCtD
Mirtazapine—Nausea—Betamethasone—multiple sclerosis	0.000109	0.000268	CcSEcCtD
Mirtazapine—Nausea—Dexamethasone—multiple sclerosis	0.000109	0.000268	CcSEcCtD
Mirtazapine—Urticaria—Methotrexate—multiple sclerosis	0.000106	0.000261	CcSEcCtD
Mirtazapine—Dizziness—Prednisone—multiple sclerosis	0.000106	0.00026	CcSEcCtD
Mirtazapine—Body temperature increased—Methotrexate—multiple sclerosis	0.000106	0.00026	CcSEcCtD
Mirtazapine—Abdominal pain—Methotrexate—multiple sclerosis	0.000106	0.00026	CcSEcCtD
Mirtazapine—Vomiting—Prednisone—multiple sclerosis	0.000102	0.00025	CcSEcCtD
Mirtazapine—Rash—Prednisone—multiple sclerosis	0.000101	0.000248	CcSEcCtD
Mirtazapine—Dermatitis—Prednisone—multiple sclerosis	0.000101	0.000248	CcSEcCtD
Mirtazapine—Headache—Prednisone—multiple sclerosis	0.0001	0.000247	CcSEcCtD
Mirtazapine—Hypersensitivity—Methotrexate—multiple sclerosis	9.84e-05	0.000242	CcSEcCtD
Mirtazapine—Asthenia—Methotrexate—multiple sclerosis	9.58e-05	0.000236	CcSEcCtD
Mirtazapine—Nausea—Prednisone—multiple sclerosis	9.49e-05	0.000234	CcSEcCtD
Mirtazapine—Pruritus—Methotrexate—multiple sclerosis	9.45e-05	0.000233	CcSEcCtD
Mirtazapine—Diarrhoea—Methotrexate—multiple sclerosis	9.14e-05	0.000225	CcSEcCtD
Mirtazapine—Dizziness—Methotrexate—multiple sclerosis	8.83e-05	0.000217	CcSEcCtD
Mirtazapine—Vomiting—Methotrexate—multiple sclerosis	8.49e-05	0.000209	CcSEcCtD
Mirtazapine—Rash—Methotrexate—multiple sclerosis	8.42e-05	0.000207	CcSEcCtD
Mirtazapine—Dermatitis—Methotrexate—multiple sclerosis	8.41e-05	0.000207	CcSEcCtD
Mirtazapine—Headache—Methotrexate—multiple sclerosis	8.37e-05	0.000206	CcSEcCtD
Mirtazapine—Nausea—Methotrexate—multiple sclerosis	7.93e-05	0.000195	CcSEcCtD
Mirtazapine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.48e-05	7.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	1.48e-05	7.31e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	1.47e-05	7.29e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—APOE—multiple sclerosis	1.47e-05	7.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	1.47e-05	7.25e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	1.46e-05	7.25e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CD80—multiple sclerosis	1.46e-05	7.23e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	1.46e-05	7.22e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.45e-05	7.19e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TYK2—multiple sclerosis	1.45e-05	7.18e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	1.44e-05	7.13e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—APOE—multiple sclerosis	1.44e-05	7.13e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.44e-05	7.11e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.43e-05	7.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.43e-05	7.08e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.43e-05	7.07e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.42e-05	7.04e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.41e-05	6.98e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.41e-05	6.98e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.41e-05	6.97e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.4e-05	6.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—POMC—multiple sclerosis	1.4e-05	6.93e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.4e-05	6.92e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TYK2—multiple sclerosis	1.39e-05	6.87e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—POMC—multiple sclerosis	1.39e-05	6.87e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.37e-05	6.8e-05	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—IL6—multiple sclerosis	1.37e-05	6.79e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.37e-05	6.79e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.37e-05	6.79e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	1.36e-05	6.74e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.36e-05	6.73e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCL2—multiple sclerosis	1.36e-05	6.72e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.35e-05	6.68e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.35e-05	6.66e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.34e-05	6.63e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.34e-05	6.62e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.33e-05	6.6e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CD80—multiple sclerosis	1.33e-05	6.59e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.33e-05	6.58e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	1.33e-05	6.58e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	1.33e-05	6.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—APOE—multiple sclerosis	1.32e-05	6.55e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.32e-05	6.52e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.32e-05	6.51e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.31e-05	6.49e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.31e-05	6.48e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.31e-05	6.47e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.31e-05	6.46e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CD80—multiple sclerosis	1.3e-05	6.45e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.29e-05	6.39e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.29e-05	6.36e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.28e-05	6.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—ALB—multiple sclerosis	1.28e-05	6.32e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.27e-05	6.3e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.27e-05	6.27e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—POMC—multiple sclerosis	1.27e-05	6.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.25e-05	6.19e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	1.24e-05	6.13e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—POMC—multiple sclerosis	1.24e-05	6.12e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.24e-05	6.12e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TYK2—multiple sclerosis	1.23e-05	6.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	1.23e-05	6.1e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL2—multiple sclerosis	1.23e-05	6.07e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	1.22e-05	6.04e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.22e-05	6.02e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.22e-05	6.02e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.21e-05	6.01e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.21e-05	6.01e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	1.21e-05	5.99e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	1.21e-05	5.99e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.21e-05	5.99e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL2—multiple sclerosis	1.21e-05	5.97e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.2e-05	5.96e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL6—multiple sclerosis	1.2e-05	5.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.2e-05	5.93e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.19e-05	5.9e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.19e-05	5.89e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	1.18e-05	5.86e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.18e-05	5.86e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.18e-05	5.83e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	1.17e-05	5.79e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	1.16e-05	5.74e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.16e-05	5.73e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL2—multiple sclerosis	1.16e-05	5.72e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.15e-05	5.7e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL6—multiple sclerosis	1.15e-05	5.69e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	1.15e-05	5.67e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MMP9—multiple sclerosis	1.14e-05	5.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.14e-05	5.63e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	1.12e-05	5.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.12e-05	5.55e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.12e-05	5.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.11e-05	5.48e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	1.1e-05	5.46e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.1e-05	5.44e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	1.1e-05	5.44e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.1e-05	5.43e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	1.1e-05	5.43e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MMP9—multiple sclerosis	1.09e-05	5.41e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.08e-05	5.33e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.08e-05	5.32e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.07e-05	5.29e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.06e-05	5.26e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—APOE—multiple sclerosis	1.05e-05	5.2e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.05e-05	5.17e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	1.04e-05	5.17e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.04e-05	5.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.04e-05	5.15e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.04e-05	5.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.04e-05	5.13e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	1.03e-05	5.11e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.03e-05	5.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.02e-05	5.07e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.02e-05	5.06e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.02e-05	5.05e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.02e-05	5.05e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.02e-05	5.03e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—STAT3—multiple sclerosis	1.02e-05	5.03e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1e-05	4.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1e-05	4.95e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1e-05	4.95e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	9.99e-06	4.94e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	9.8e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—STAT3—multiple sclerosis	9.72e-06	4.81e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	9.71e-06	4.81e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MYC—multiple sclerosis	9.59e-06	4.74e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	9.57e-06	4.73e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	9.51e-06	4.71e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	9.44e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MYC—multiple sclerosis	9.44e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	9.42e-06	4.66e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	9.38e-06	4.64e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.38e-06	4.64e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL2—multiple sclerosis	9.35e-06	4.63e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	9.31e-06	4.6e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	9.31e-06	4.6e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	9.29e-06	4.6e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	9.28e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	9.27e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	9.23e-06	4.57e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL2—multiple sclerosis	9.15e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.1e-06	4.51e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	9.1e-06	4.5e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	9.09e-06	4.5e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MYC—multiple sclerosis	9.04e-06	4.47e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—POMC—multiple sclerosis	9.03e-06	4.47e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	9.01e-06	4.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	8.95e-06	4.43e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	8.9e-06	4.4e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	8.9e-06	4.4e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	8.86e-06	4.38e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	8.85e-06	4.38e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	8.84e-06	4.37e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	8.66e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	8.66e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	8.64e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOE—multiple sclerosis	8.63e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	8.63e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	8.61e-06	4.26e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	8.6e-06	4.26e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOE—multiple sclerosis	8.55e-06	4.23e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	8.47e-06	4.19e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	8.45e-06	4.18e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	8.44e-06	4.18e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	8.42e-06	4.17e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ALB—multiple sclerosis	8.23e-06	4.07e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	8.19e-06	4.05e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MYC—multiple sclerosis	8.03e-06	3.97e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	8.01e-06	3.96e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	7.87e-06	3.89e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—multiple sclerosis	7.85e-06	3.89e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	7.85e-06	3.89e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	7.81e-06	3.87e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	7.73e-06	3.82e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—multiple sclerosis	7.71e-06	3.82e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	7.7e-06	3.81e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	7.69e-06	3.81e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	7.67e-06	3.8e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	7.57e-06	3.74e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	7.53e-06	3.73e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	7.53e-06	3.73e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	7.49e-06	3.71e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	7.43e-06	3.68e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—POMC—multiple sclerosis	7.41e-06	3.67e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—POMC—multiple sclerosis	7.35e-06	3.64e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	7.31e-06	3.62e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—multiple sclerosis	7.31e-06	3.62e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOE—multiple sclerosis	7.31e-06	3.62e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	7.3e-06	3.61e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	7.3e-06	3.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	7.28e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—multiple sclerosis	7.21e-06	3.57e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	7.16e-06	3.54e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	7.15e-06	3.54e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—multiple sclerosis	7.15e-06	3.54e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	7.14e-06	3.53e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—multiple sclerosis	7.1e-06	3.51e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	7.03e-06	3.48e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	7e-06	3.46e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	7e-06	3.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	6.99e-06	3.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	6.98e-06	3.45e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	6.96e-06	3.44e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	6.94e-06	3.44e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	6.84e-06	3.39e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	6.81e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—multiple sclerosis	6.79e-06	3.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	6.77e-06	3.35e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—multiple sclerosis	6.76e-06	3.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	6.75e-06	3.34e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—multiple sclerosis	6.7e-06	3.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	6.65e-06	3.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	6.62e-06	3.28e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	6.61e-06	3.27e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	6.5e-06	3.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	6.49e-06	3.21e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	6.48e-06	3.21e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	6.37e-06	3.15e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—POMC—multiple sclerosis	6.28e-06	3.11e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—multiple sclerosis	6.14e-06	3.04e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	6.13e-06	3.03e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	6.04e-06	2.99e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—multiple sclerosis	6.03e-06	2.99e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—multiple sclerosis	6.03e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	6.03e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	6.02e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	6.01e-06	2.97e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	5.92e-06	2.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	5.92e-06	2.93e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	5.91e-06	2.93e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	5.9e-06	2.92e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	5.9e-06	2.92e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	5.79e-06	2.86e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—multiple sclerosis	5.72e-06	2.83e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOE—multiple sclerosis	5.64e-06	2.79e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	5.5e-06	2.72e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—multiple sclerosis	5.5e-06	2.72e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	5.48e-06	2.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	5.38e-06	2.66e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—multiple sclerosis	5.38e-06	2.66e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	5.26e-06	2.6e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	5.23e-06	2.59e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	5.09e-06	2.52e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—POMC—multiple sclerosis	4.85e-06	2.4e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—multiple sclerosis	4.62e-06	2.28e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	4.54e-06	2.25e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—multiple sclerosis	4.53e-06	2.24e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	4.45e-06	2.2e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.42e-06	2.19e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	4.13e-06	2.05e-05	CbGpPWpGaD
